These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31999070)

  • 1. The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look-backs to look-ahead.
    Baloch Z; LiVolsi VA
    Diagn Cytopathol; 2020 Oct; 48(10):862-866. PubMed ID: 31999070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel.
    Pusztaszeri M; Rossi ED; Auger M; Baloch Z; Bishop J; Bongiovanni M; Chandra A; Cochand-Priollet B; Fadda G; Hirokawa M; Hong S; Kakudo K; Krane JF; Nayar R; Parangi S; Schmitt F; Faquin WC
    Acta Cytol; 2016; 60(5):399-405. PubMed ID: 27764825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis.
    Vuong HG; Ngo HTT; Bychkov A; Jung CK; Vu TH; Lu KB; Kakudo K; Kondo T
    Cancer Cytopathol; 2020 Apr; 128(4):238-249. PubMed ID: 31883438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions.
    Crowe A; Linder A; Hameed O; Salih C; Roberson J; Gidley J; Eltoum IA
    Cancer Cytopathol; 2011 Oct; 119(5):315-21. PubMed ID: 21751427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
    Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
    Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bethesda System for Reporting Thyroid Cytopathology: proposed modifications and updates for the second edition from an international panel.
    Pusztaszeri M; Rossi ED; Auger M; Baloch Z; Bishop J; Bongiovanni M; Chandra A; Cochand-Priollet B; Fadda G; Hirokawa M; Hong S; Kakudo K; Krane JF; Nayar R; Parangi S; Schmitt F; Faquin WC
    J Am Soc Cytopathol; 2016; 5(5):245-251. PubMed ID: 31042501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
    Arnold MA; Nicol KK
    Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of the Bethesda System for Reporting Thyroid Cytopathology: observations from the 2011 thyroid supplemental questionnaire of the College of American Pathologists.
    Auger M; Nayar R; Khalbuss WE; Barkan GA; Benedict CC; Tambouret R; Schwartz MR; Howell LP; Souers RJ; Hartley DA; Thomas N; Moriarty AT
    Arch Pathol Lab Med; 2013 Nov; 137(11):1555-9. PubMed ID: 24168494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area.
    Lee YB; Cho YY; Jang JY; Kim TH; Jang HW; Chung JH; Oh YL; Kim SW
    Head Neck; 2017 Feb; 39(2):269-274. PubMed ID: 27617626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between conventional and the Bethesda System for Reporting Thyroid Cytology of 240 cases.
    Pandey P; Dixit A; Sawhney A; Ralli M; Chaturvedi V; Agarwal S; Singh JP; Gupta S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S253-S258. PubMed ID: 36510973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation.
    Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P
    Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cytopathology: Bethesda and beyond.
    Ali SZ
    Acta Cytol; 2011; 55(1):4-12. PubMed ID: 21135515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bethesda System for Reporting Thyroid Cytopathology Explained for Practitioners: Frequently Asked Questions.
    Bongiovanni M; Papadakis GE; Rouiller N; Marino L; Lamine F; Bisig B; Ziadi S; Sykiotis GP
    Thyroid; 2018 May; 28(5):556-565. PubMed ID: 29591914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
    Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
    Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Suspicious for a follicular neoplasm' before and after the Bethesda System for Reporting Thyroid Cytopathology: impact of standardized terminology.
    Boonyaarunnate T; Olson MT; Ali SZ
    Acta Cytol; 2013; 57(5):455-63. PubMed ID: 24021843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlative study of solitary thyroid nodules using the bethesda system for reporting thyroid cytopathology.
    Arul P; Masilamani S
    J Cancer Res Ther; 2015; 11(3):617-22. PubMed ID: 26458591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of histological classification and cytology reporting format of the Japanese General Rules for the Description of Thyroid Cancer with a special focus on the differences of the WHO Histological Classification and The Bethesda System of Thyroid Cytology.
    Sakamoto A; Hirokawa M; Ito M; Naganuma H; Suzuki O; Hashimoto Y; Suzuki S; Shimura H
    Endocr J; 2021 Jun; 68(6):621-630. PubMed ID: 33853988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
    Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bethesda System in the evaluation of thyroid nodules: Review.
    Wesoła M; Jeleń M
    Adv Clin Exp Med; 2017; 26(1):177-182. PubMed ID: 28397450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.